Perspective Therapeutics Inc (CATX)
Stock-Based Compensation
$3.05M
Quarterly · Period ending: · USD
CATX Stock-Based Compensation
Latest reported$3.05Mperiod ending
Latest reported$3.05Mperiod ending
CATX Quarterly Stock-Based Comp ($0.00 → $3.05M)
Quarterly stock-based compensation
High-resolution chart · PNG
CATX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 3,046,000 | |
| 2,553,000 | |
| 2,309,000 | |
| 2,156,000 | |
| 2,403,000 | |
| 2,098,000 | |
| 2,060,000 | |
| 1,952,000 | |
| 719,000 | |
| 656,000 | |
| 720,000 | |
| 451,000 | |
| 1,199,000 | |
| 1,368,000 | |
| 0 | |
| 465,000 | |
| 154,000 | |
| 157,000 | |
| 180,000 | |
| 596,000 | |
| 126,000 | |
| 94,000 | |
| 81,000 | |
| 85,000 | |
| 219,000 | |
| 91,000 | |
| 94,000 | |
| 91,000 | |
| 151,000 | |
| 79,000 | |
| 97,000 | |
| 93,000 | |
| 290,000 | |
| 77,000 | |
| 150,000 | |
| 90,000 | |
| 210,000 | |
| 40,000 | |
| 52,000 | |
| 70,000 | |
| 60,870 | |
| 166,000 | |
| 31,000 | |
| 32,000 | |
| 140,904 | |
| 21,453 | |
| 21,454 | |
| 21,453 | |
| 120,770 | |
| 13,431 | |
| 13,433 | |
| 38,353 | |
| 22,982 | |
| 27,580 | |
| 28,826 | |
| 28,963 | |
| 73,755 | |
| 33,189 | |
| 33,190 | |
| 33,189 | |
| 174,067 | |
| 20,372 | |
| 23,658 | |
| 24,592 | |
| 157,748 | |
| 34,808 | |
| 22,550 | |
| 57,927 | |
| 98,246 | |
| 55,668 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |